checkAd
    Startseite > Aktien > Terns Pharmaceuticals > Nachrichten
    Terns Pharmaceuticals Aktie
    6,3200
     
    USD
    +5,33 %
    +0,3200 USD
    Letzter Kurs 02:00:00 Nasdaq
    6,3100
     
    USD
    100 STK
    Geldkurs 28.05.24
    6,3200
     
    USD
    700 STK
    Briefkurs 28.05.24
    ISIN: US8808811074 · WKN: A2QNWR · SYM: TERN · USA

    Neueste Nachrichten

    Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day
    17.05.24 · globenewswire · Terns Pharmaceuticals
    Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
    13.05.24 · globenewswire · Terns Pharmaceuticals
    Terns Pharmaceuticals Announces Leadership Changes
    08.05.24 · globenewswire · Terns Pharmaceuticals
    Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
    07.05.24 · globenewswire · Terns Pharmaceuticals
    Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
    03.05.24 · globenewswire · Terns Pharmaceuticals
    Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation
    29.04.24 · globenewswire · Terns Pharmaceuticals
    Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
    10.04.24 · globenewswire · Terns Pharmaceuticals
    Fokus Aktien mit extremen Handelsvolumen am Montag, den 08.04.2024
    08.04.24 · wO Chartvergleich · Aaon
    Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
    14.03.24 · globenewswire · Terns Pharmaceuticals
    Fokus Aktien mit extremen Handelsvolumen am Mittwoch, den 13.03.2024
    13.03.24 · wO Chartvergleich · ANZ Group Holdings
    Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
    11.03.24 · globenewswire · Terns Pharmaceuticals
    Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
    07.03.24 · globenewswire · Terns Pharmaceuticals